Paxlovid — the only medication people can take at home to treat an active case of Covid — is now being studied as a potential treatment for those who have remained sick months or even years following infection.
"It is known that Covid can go to multiple sites in the body," she said."The question is, does it set up shop there? And is it quiet enough so that our immune system is not getting rid of it adequately?"
Half of them will get the actual drug, while the others will get a placebo. While Paxlovid is generally given for five days, this study will have participants take it for 15. This is meant, in part, to address the possibility that the drug needs more time to work well. Many patients newly diagnosed with Covid have reported rebound symptoms after their typical five-day treatment course.There is already evidence people who take Paxlovid for Covid are less likely to develop long-lasting symptoms.
Dr. Ziyad Al-Aly, a clinical epidemiologist at Washington University in St. Louis, led the study. The leading long Covid researcher said that while he is eager to see how Paxlovid does in the Stanford study, he suspects that the drug may not be useful after someone has already been suffering for a while.
Others get worse, especially if they become re-infected, said Dr. Monica Verduzco-Gutierrez, the chair of the department of rehabilitation medicine at the Long School of Medicine at UT Health San Antonio. She is not involved with either the Stanford or the VA research.Verduzco-Gutierrez said that studying Paxlovid in people with long Covid"makes sense" because"sometimes viruses hide in certain cells, and it's hard to get to them.""I don't know," she said.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Major Chinese city in near-lockdown after record Covid cases and iPhone worker protestsThe Chinese city of Zhengzhou, home to the world’s biggest Apple iPhone factory, largely goes into lockdown amid a growing Covid outbreak. The restrictions come a day after violent protests broke out near a factory run by Foxconn, Apple’s main supplier.
Read more »
'The Long COVID Survival Guide' to finding care and community : It's Been a MinuteAccording to the CDC, out of all the American adults who have had COVID — and that's a lot of us — one in five went on to develop long COVID symptoms. While so many are struggling with this new disease, it can be hard for people to know how to take care of themselves. The Long COVID Survival Guide aims to give people struggling with long COVID practical solutions and emotional support to manage their illness. Host Brittany Luse talks to Fiona Lowenstein, editor of the guide, and Karla Monterroso, one of the contributors, about the difficulty of getting diagnosed, navigating long COVID and creating long-term collective care. You can follow us on Twitter NPRItsBeenAMin and email us at ibamnpr.org.
Read more »
First Real-World Data Show That the Bivalent Booster Is EffectiveThe latest booster, which targets two Omicron variants, offers protection from severe COVID-19
Read more »
5 things to know for November 23: Walmart shooting, Trump, Student loans, Layoffs, Covid | CNNHere are 5️⃣ things you need to know today 👇 1️⃣ Walmart mass shooting 2️⃣ Donald Trump’s tax returns 3️⃣Student loan forgiveness 4️⃣ Tech layoffs 5️⃣ Covid-19 booster push
Read more »
They died suddenly - then the anti-vax trolling startedA new 'documentary' falsely blames Covid vaccines for deaths of young people.
Read more »
N.J. man admits he lied to get $852K in COVID emergency relief loansThe North Plainfield man allegedly used part of the money to buy property in New Jersey, court documents said.
Read more »